Pei-LingChenMD

Dermatopathology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Chen?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 23 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Pei-Ling Chen, MD is a board certified pathologist in Saint Louis, Missouri. She is currently licensed to practice medicine in Missouri and Florida. She is affiliated with H. Lee Moffitt Cancer Center and Research Institute.

Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 2010 - 2014
The Warren Alpert Medical School of Brown UniversityClass of 2003
University of Texas M D Anderson Cancer CenterFellowship, Dermatopathology

PubMed

1039 citations
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy
Weiyi Peng, Jie Qing Chen, Chengwen Liu, Shruti Malu, Caitlin Creasy
Cancer Discovery. 2016-02-01
22 citations
Fucosylation of HLA-DRB1 regulates CD4T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy.
Daniel K Lester, Chase Burton, Alycia Gardner, Patrick Innamarato, Krithika Kodumudi
Nature Cancer. 2023-02-01
681 citations
Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Pei Ling Chen, Whijae Roh, Alexandre Reuben, Zachary A. Cooper, Christine N. Spencer
Cancer Discovery. 2016-08-01

Genomic Alterations Identified in Cutaneous T-cell Lymphoma Could Provide Path to New TherapiesMarch 1st, 2022
Key Genomic Alterations and Potential Therapeutic Vulnerabilities Identified in Transformed Cutaneous T-cell LymphomaMarch 1st, 2022